UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030930
Receipt number R000035328
Scientific Title Study on efficacy and safety of the simultaneous treatment with febuxostat and inosine of patients with Parkinson's disease.
Date of disclosure of the study information 2019/01/01
Last modified on 2020/12/17 16:59:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study on efficacy and safety of the simultaneous treatment with febuxostat and inosine of patients with Parkinson's disease.

Acronym

Effect of febuxostat and inosine on Parkinson's disease

Scientific Title

Study on efficacy and safety of the simultaneous treatment with febuxostat and inosine of patients with Parkinson's disease.

Scientific Title:Acronym

Effect of febuxostat and inosine on Parkinson's disease

Region

Japan


Condition

Condition

Parkinson's disease

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Examine efficacy and safety of simultaneous administration of febuxostat and inosine for patients with Parkinson's disease for 8 weeks.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Difference of MDS-UPDRS Part III score before registration and after 57 days of the treatment

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Administration of febuxostat 20 mg and inosine 500 mg twice a day for 58 days

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Japanese patient who gave voluntary written consent with regard to study participation
2. Patient with 20 to 80 years of age
3. Gender: male or female
4. Patient who has been diagnosed with Parkinson's disease and fulfill all the following criteria,
Hoehn-Yahr scale stage 1-3
MDS-UPDRS Part III score not less than 15
MMSE score not less than 24

Key exclusion criteria

(1) Patient who requires nearly full assistance in one's daily life, is incapable of walking and standing
(2) Patient taking azathioprine, mercaptopurine hydrate, vidarabine or didanosine
(3) Patient whose serum creatinine exceeds 1.5 times the upper limit of the reference value or whose AST (GOT) or ALT (GPT) exceeds the upper limit of the reference value in the pre-registration examination
(4) Patient who has undergone surgical treatment for Parkinson's disease
(5) Patient with a history or a current illness of gout, hyperuricaemia or urolithiasis
(6) Patient who has been treated with febuxostat
(7) Patient who has a history or a present illness of hypersensitivity / Idiosyncratic reaction (allergy) to a drug or drugs
(8) Patient who has used an investigational drug within 30 days before the consent
(9) Patient with pregnancy or a possibility of pregnancy, or lactating patient
(10) Patient judged inappropriate with other reasons by a principal investigator or a subinvestigator

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Gen
Middle name
Last name Sobue

Organization

Nagoya University Graduate School of Medicine

Division name

Brain and Mind Research Center

Zip code

466-8560

Address

Tsurumai-machi 65, Showa-ku, Nagoya, Aichi

TEL

052-741-2111

Email

sobueg@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name Naoyuki
Middle name
Last name Kamatani

Organization

StaGen Co. Ltd.

Division name

Research Institute for Artificial Intelligence in Medicine

Zip code

111-0051

Address

KUGA Bldg 8F, 4-11-6 Kuramae, Taito-ku, Tokyo

TEL

03-5835-2137

Homepage URL


Email

kamatani@msb.biglobe.ne.jp


Sponsor or person

Institute

StaGen Co. Ltd.

Institute

Department

Personal name



Funding Source

Organization

StaGen Co. Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Review Board of Human Rights and Ethics for Clinical Studies

Address

Ichibancho 13-2, Chiyoda-ku, Tokyo

Tel

03-5213-0028

Email

secretariat@hurecs.org


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 12 Month 25 Day

Date of IRB

2017 Year 12 Month 22 Day

Anticipated trial start date

2018 Year 01 Month 29 Day

Last follow-up date

2018 Year 10 Month 03 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 01 Month 22 Day

Last modified on

2020 Year 12 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035328


Research Plan
Registered date File name
2020/12/20 試験実施計画書.pdf

Research case data specifications
Registered date File name
2020/12/20 症例報告書.pdf

Research case data
Registered date File name